Pfizer (NYSE:PFE) has decided to end R&D and marketing activities related to Beqvez, a one-time gene therapy the company has ...
Roche (RHHBY) unveiled its proprietary, breakthrough sequencing by expansion technology, establishing a new category of next-generation ...
Has drug giant Roche finally cracked DNA sequencing? The company has claimed it can decode the genome in as little as four ...
Sebastian Roché hasn’t ruled out a General Hospital return just yet. “Never say never,” Roché, 60, told Us Weekly exclusively ...
RBC Capital reiterated an Outperform rating and $247 price target on Illumina (ILMN) after Roche (RHHBY) presented scientific details about its ...
Roche Holding AG's ( VTX:ROG ) dividend will be increasing from last year's payment of the same period to CHF9.70 ...
Roche's sale of InterMune and Esbriet in the US comes as Boehringer revealed its own follow-up play in the IPF, category, ...
The FDA on Wednesday approved the industry’s first-ever tablet treatment for spinal muscular atrophy— Roche ’s SMN2 splicing ...
Roche's innovative sequencing by expansion (SBX) technology represents a leap forward in next-generation sequencing (NGS), which is playing a vital role in decoding complex diseases like cancer, ...
10h
Briefly on MSNSophie Ndaba Celebrated As Host for Roche Africa Press Day 2025, SA Gives Flowers: "A True Warrior"South African actress Sophie Ndaba was invited to speak on all things women's health at the Roche Africa Press Day 2025.
Deutsche Bank analyst Emmanuel Papadakis maintained a Sell rating on Roche Holding AG (RHHVF – Research Report) today and set a price target ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results